Perri Michael G, Limacher Marian C, von Castel-Roberts Kristina, Daniels Michael J, Durning Patricia E, Janicke David M, Bobroff Linda B, Radcliff Tiffany A, Milsom Vanessa A, Kim Chanmin, Martin A Daniel
Department of Clinical and Health Psychology, University of Florida College of Public Health and Health Professions, Gainesville, Florida, USA.
Obesity (Silver Spring). 2014 Nov;22(11):2293-300. doi: 10.1002/oby.20832.
To evaluate the effects and costs of three doses of behavioral weight-loss treatment delivered via Cooperative Extension Offices in rural communities.
Obese adults (N = 612) were randomly assigned to low, moderate, or high doses of behavioral treatment (i.e., 16, 32, or 48 sessions over two years) or to a control condition that received nutrition education without instruction in behavior modification strategies.
Two-year mean reductions in initial body weight were 2.9% (95% Credible Interval = 1.7-4.3), 3.5% (2.0-4.8), 6.7% (5.3-7.9), and 6.8% (5.5-8.1) for the control, low-, moderate-, and high-dose conditions, respectively. The moderate-dose treatment produced weight losses similar to the high-dose condition and significantly larger than the low-dose and control conditions (posterior probability > 0.996). The percentages of participants who achieved weight reductions ≥ 5% at two years were significantly higher in the moderate-dose (58%) and high-dose (58%) conditions compared with low-dose (43%) and control (40%) conditions (posterior probability > 0.996). Cost-effectiveness analyses favored the moderate-dose treatment over all other conditions.
A moderate dose of behavioral treatment produced two-year weight reductions comparable to high-dose treatment but at a lower cost. These findings have important policy implications for the dissemination of weight-loss interventions into communities with limited resources.
评估通过农村社区合作推广办公室提供的三种剂量行为减肥治疗的效果和成本。
肥胖成年人(N = 612)被随机分配到低、中、高剂量行为治疗组(即两年内分别为16、32或48节课程)或接受无行为改变策略指导的营养教育的对照组。
对照组、低剂量组、中剂量组和高剂量组的初始体重在两年内的平均降低幅度分别为2.9%(95%可信区间 = 1.7 - 4.3)、3.5%(2.0 - 4.8)、6.7%(5.3 - 7.9)和6.8%(5.5 - 8.1)。中剂量治疗产生的体重减轻与高剂量组相似,且显著大于低剂量组和对照组(后验概率 > 0.996)。与低剂量组(43%)和对照组(40%)相比,两年内体重减轻≥5%的参与者百分比在中剂量组(58%)和高剂量组(58%)中显著更高(后验概率 > 0.996)。成本效益分析表明,中剂量治疗优于所有其他治疗。
中等剂量的行为治疗在两年内产生的体重减轻与高剂量治疗相当,但成本更低。这些发现对向资源有限的社区推广减肥干预措施具有重要的政策意义。